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Dioxins, a class of environmental pollutants
resulting from the production and combustion
of chlorinated compounds, have been shown
to cause cardiovascular toxicity in animals
(Dalton et al. 2001; Jokinen et al. 2003; Kopf
et al. 2007; Lind et al. 2004). Although a
number of epidemiologic studies have exam-
ined the association of dioxin exposure with
cardiovascular disease (CVD) morbidity or
mortality, we found no published systematic
reviews on this topic, possibly because dioxin
epidemiology research has focused primarily
on the association with various cancers
[International Agency for Research on Cancer
(IARC) 1997; National Academy of Sciences
2007]. In this review we focus on CVD mor-
tality. Given the large worldwide burden of
CVD, the potential role of dioxin exposure as
a preventable risk factor could be of substantial
public health and clinical interest, especially in
the context of recent reports of elevated envi-
ronmental dioxin levels in China (Leung et al.
2007; Li et al. 2007, 2008) and ubiquitous
low levels worldwide (Schecter et al. 2006).
Deﬁnition of “dioxin.” The term “dioxin”
refers to a diverse group of structurally related,
environmentally persistent chemicals that
exert toxic effects through a common pathway
mediated by the aryl hydrocarbon receptor
(Van den Berg et al. 1998, 2006). Dioxins
include several types of polyhalogenated
aromatic hydrocarbons: polychlorinated
dibenzofurans (PCDFs); some types of poly-
chlorinated biphenyls (PCBs); and polychlori-
nated dibenzo-p-dioxins (PCDDs), including
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD),
the most potent member of this class of chem-
icals. Although “dioxin” is also sometimes
used to refer to TCDD alone, in this review
we use the broader deﬁnition.
Animal and laboratory evidence. Although
studies have demonstrated that the fetal mam-
malian heart is a sensitive target of TCDD-
induced teratogenicity (Thackaberry et al.
2005), only in the past few years have toxico-
logic studies demonstrated cardiovascular
effects after exposure to dioxins in adult rats
and mice. These effects did not seem to occur
as a result of overt toxicity. Chronic exposure
of rats to either TCDD or PCB-126, the most
potent of the dioxin-like PCBs, led to a dose-
dependent increased incidence of degenerative
cardiovascular lesions, including cardio-
myopathy and chronic active arteritis (Jokinen
et al. 2003). PCB-126 also increased heart
weight, serum cholesterol levels, and blood
pressure in rats (Lind et al. 2004). Adult mice
exposed subchronically to TCDD developed
increased blood pressure and heart weight, as
well as elevated markers of oxidative stress
(Kopf et al., in press). Increased blood pres-
sure and triglyceride levels were also observed
after an acute high dose of TCDD in mice
(Dalton et al. 2001). ApoE–/– mice exposed to
subchronic doses of TCDD also developed
earlier and more severe atherosclerotic lesions
(Dalton et al. 2001). Some of these changes
may be due to altered gene expression, inﬂam-
mation, and oxidative stress (Arzuaga et al.
2007; Lund et al. 2005), whereas others may
relate to direct affects on cardiomyocytes
involving dioxin perturbation of key calcium
signaling pathways leading to abnormal depo-
larization (Xie et al. 2006). Recent evidence
that TCDD causes mitochondrial dysfunction
in cell culture (Biswas et al. 2008) may suggest
an additional mechanism for the effect of
dioxin on the cardiovascular system. Such
molecular, physiologic, and morphologic
effects in rodent models all provide biological
plausibility to the association observed in epi-
demiologic studies between exposure to diox-
ins and CVD mortality.
Methods
Search strategy and selection criteria. We
found articles by searching PubMed (National
Library of Medicine 2007) in December 2007
using the keyword “mortality” in combination
with each of the following: dioxin, TCDD,
PCDD, PCDF, phenoxy, chlorophenoxy,
chlorophenol, and trichlorophenol. From this
initial list, we selected studies that reported
original epidemiologic data on mortality, in
English, from either all cases of CVD, or
ischemic heart disease (IHD). Other subtypes
of CVD mortality (e.g., hypertension) were
inconsistently reported; therefore, we did not
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OBJECTIVE: In this systematic review we evaluated the evidence on the association between dioxin
exposure and cardiovascular disease (CVD) mortality in humans.
DATA SOURCES AND EXTRACTION: We conducted a PubMed search in December 2007 and consid-
ered all English-language epidemiologic studies and their citations regarding dioxin exposure and
CVD mortality. To focus on dioxins, we excluded cohorts that were either primarily exposed to
polychlorinated biphenyls or from the leather and perfume industries, which include other cardio-
toxic coexposures.
DATA SYNTHESIS: We included results from 12 cohorts in the review. Ten cohorts were occupation-
ally exposed. We divided analyses according to two well-recognized criteria of epidemiologic study
quality: the accuracy of the exposure assessment, and whether the exposed population was compared
with an internal or an external (e.g., general population) reference group. Analyses using internal
comparisons with accurate exposure assessments are the highest quality because they minimize both
exposure misclassiﬁcation and confounding due to workers being healthier than the general popula-
tion (“healthy worker effect”). The studies in the highest-quality group found consistent and signiﬁ-
cant dose-related increases in ischemic heart disease (IHD) mortality and more modest associations
with all-CVD mortality. Their primary limitation was a lack of adjustment for potential confound-
ing by the major risk factors for CVD.
CONCLUSIONS: The results of this systematic review suggest that dioxin exposure is associated with
mortality from both IHD and all CVD, although more strongly with the former. However, it is not
possible to determine the potential bias, if any, from confounding by other risk factors for CVD.
KEY WORDS: cardiovascular disease, dioxin, epidemiology, healthy worker effect, herbicides, ischemic
heart disease, mortality, occupational exposure, PCB, TCDD. Environ Health Perspect 116:1443–1448
(2008). doi:10.1289/ehp.11579 available via http://dx.doi.org/ [Online 22 July 2008]examine them in this review. Figure 1 illus-
trates the study selection process. 
We excluded studies with insufﬁcient evi-
dence of exposure to dioxin (e.g., ecologic
studies, studies of Vietnam veterans not
involved in herbicide spraying, or studies of
pesticide applicators without information on
which pesticides were used and whether
dioxin contamination was possible). We also
excluded studies whose primary exposure was
to PCBs. Only 12 of 209 PCBs have dioxin-
like activity, so exposure to non–dioxin-like
PCBs would complicate the interpretation of
any association of total PCBs with CVD.
Although dioxin exposure may occur dur-
ing leather tanning and processing (Mikoczy
et al. 1994) and in ﬂavor and fragrance pro-
duction (Thomas 1987), we excluded studies
of cohorts from these industries due to the
multiple cardiotoxic coexposures involved,
including methylmercury, arsenic, and xylene.
If several follow-up studies had been pub-
lished for a cohort, we included only the most
recent results. By necessity, we made an excep-
tion when applying this rule to the IARC
multicenter cohort, which updated and pooled
the results of 36 individual cohorts (Vena et al.
1998). We did not include the earlier publica-
tions from these cohorts, as our protocol speci-
ﬁed. The difﬁculty arose when four cohorts that
were included in the IARC multicenter study
subsequently published additional results: either
additional follow-up time (Flesch-Janys et al.
1995; Steenland et al. 1999; ‘t Mannetje et al.
2005), or identical follow-up time but with
more detailed exposure assessments (Hooiveld
et al. 1998). Because the new results from these
studies provided additional information, but
the older results could not be dissociated from
the summary relative risks (RRs) of the IARC
study, we had no alternative but to effectively
include these four studies twice; once as com-
ponents of the IARC results, and then again as
updated individual publications. Because these
study results are therefore not independent, we
did not attempt to quantitatively combine the
RRs in a meta-analysis. 
Results
Description of included studies. Eleven cohorts
(Asp et al. 1994; Bertazzi et al. 2001; Flesch-
Janys et al. 1995, 1998; Hertzman et al. 1997;
Hooiveld et al. 1998; Ketchum and Michalek
2005; Ott and Zober 1996; Steenland et al.
1999; ‘t Mannetje et al. 2005; Tsai et al. 2007;
Vena et al. 1998) remained after we applied
the exclusion criteria to the 393 initial
PubMed search results (Figure 1). We identi-
ﬁed one additional cohort (Dalager and Kang
1997) by searching the citations, for a total of
12 included cohorts. Ten involved occupa-
tional or military exposure to dioxins, whereas
the other two were environmentally exposed
(Bertazzi et al. 2001; Tsai et al. 2007). One
study was a large, multicenter cohort study
(Vena et al. 1998) conducted by IARC, which
examined noncancer mortality from 36 occu-
pational cohorts and 26,976 workers poten-
tially exposed to TCDD or other highly
chlorinated dioxins. Of the 11 other cohorts,
4 were also part of the IARC study (Flesch-
Janys et al. 1995; Hooiveld et al. 1998;
Steenland et al. 1999; ‘t Mannetje et al. 2005),
but we still included them separately in this
review because they subsequently published
additional follow-up or more detailed analyses.
Although quantitative dioxin exposure pro-
ﬁles for each cohort were not available because
limited biological measurements were per-
formed, broad exposure categorizations are pos-
sible. The workers in the 10 occupational
cohorts were primarily exposed to PCDDs
through the production and/or application of
phenoxy acid herbicides and chlorophenols
(Vena et al. 1998), with some possible PCDF
exposure, as well (Becher et al. 1996). Of the
remaining two studies, the Italian Seveso popu-
lation (Bertazzi et al. 2001) was acutely exposed
to high levels of environmental TCDD conta-
mination after an industrial accident, whereas
the Taiwanese Yucheng population (Tsai et al.
2007) was acutely exposed to a mixture of
PCDFs and PCBs from ingesting contaminated
rice oil. The latter study was included in spite of
the PCB coexposures, because the toxic effects
have been suggested to correlate more closely
with exposure to PCDFs (Ryan et al. 1990).
Criteria of study design quality. We
grouped study results according to two well-
recognized criteria of study design quality. The
ﬁrst criterion was whether mortality among the
exposed participants was compared with an
internal or an external reference group.
External comparisons used standardized mor-
tality ratios (SMRs) to compare the number of
deaths observed in the exposed group (e.g.,
dioxin-exposed factory workers) with the num-
ber of deaths expected in the general popula-
tion, standardized for age and sex. The primary
limitation of external comparisons is that
whenever the exposed group is an employed
population, associations between exposure and
CVD mortality will be biased downward (gen-
erally below the null) because workers are
healthier on average than the general popula-
tion (McMichael 1976) (“healthy worker
effect”). Internal comparison studies instead
contrast the highest-exposed groups with the
lowest-exposed group in the study population,
which minimizes the healthy worker effect bias
if the cohort is occupational, as well as poten-
tial confounding by other factors that do not
vary within the study population. For these
reasons, internal comparisons are of higher
quality than external comparisons.
The second criterion we used to evaluate
studies in this review was exposure assessment
quality. Many studies had little information
on exposure level and therefore considered all
members of the exposed group to be equally
exposed. Because of these crude exposure esti-
mates, the exposed groups may have contained
individuals with low or no actual exposure.
This nondifferential misclassification would
tend to dilute any associations between
exposure and CVD mortality, biasing the
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Figure 1. Flow diagram of study selection process using PubMed.
aUsing the “limits” feature in PubMed. bThe only exception is described in “Methods.” cThe relevant results from the
Hamburg study were divided into two publications. dThese 509 references include replicates of articles cited in multiple
publications. 
PubMed search results (n = 393)
References manually reviewed (n = 188)
Preliminary references (n = 12)
Cohorts (n = 11)c
Citations in preliminary
references (n = 509)d
References excluded (n = 508)
Same exclusion criteria as above.
Total references (n = 13)
Total cohorts (n = 12)
Occupational populations (n = 10)
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References excluded (n = 205)a
Language other than English
Nonhuman research
References excluded (n = 176)
No original data or no human data
No CVD or IHD mortality outcomes
Insufficient evidence of dioxin exposure
Primary exposure to PCBs
Industries with cardiotoxic exposures
Multiple publications from same populationbassociations downward. In contrast, some
studies were able to conduct more detailed
exposure assessments, using exposure measures
that varied in complexity from dichotomous
yes/no exposure among workers (IARC), to
septiles of cumulative exposure [National
Institute for Occupational Safety and Health
(NIOSH)]. Additional details on these studies’
personal exposure assessments can be found in
the original articles (Bertazzi et al. 2001;
Flesch-Janys et al. 1995; Hooiveld et al. 1998;
Ketchum and Michalek 2005; Ott and Zober
1996; Steenland et al. 1999; Vena et al. 1998).
Crude exposure assessments, with either
internal or external comparisons. Table 1 pre-
sents the results of analyses using the crudest
exposure assessments (i.e., only exposed vs.
unexposed), with either internal or external
comparisons. Most external comparison stud-
ies in this group found no elevated SMRs for
either IHD or all CVD. This included the
Seveso (Bertazzi et al. 2001) and Yucheng
(Tsai et al. 2007) studies, even though no
healthy worker effect bias was present because
the exposed were part of the general popula-
tion. Of the two internal comparison studies,
the Ranch Hand study (Ketchum and
Michalek 2005) showed a modestly elevated
RR for all CVD (RR = 1.3; p = 0.07), whereas
the Army Chemical Corps study (Dalager and
Kang 1997) did not show an increased risk
(RR = 1.06; 0.62–1.82).
Detailed exposure assessments, with exter-
nal comparisons. Four studies conducted
external comparisons but stratiﬁed their SMRs
by detailed exposure level (Bertazzi et al. 2001;
Ott and Zober 1996; Steenland et al. 1999;
Vena et al. 1998). Because external compar-
isons were used in these studies, healthy
worker effect bias may be present in the three
studies in which the exposed group had occu-
pational exposure (Ott and Zober 1996;
Steenland et al. 1999; Vena et al. 1998), but
not in the fourth study (Seveso), in which the
exposed group was environmentally exposed
(Bertazzi et al. 2001). These results are not
shown separately because three of the four
studies also included internal comparisons
(Table 2) and found similar results.
In the Seveso study, Bertazzi et al. (2001)
calculated the SMRs in the highest and sec-
ond-highest exposure zones. Exposure in this
study was ecologically deﬁned by proximity to
the site of an industrial accident. The IHD
SMRs [95% conﬁdence intervals (CIs)] were
0.8 (0.4–1.5) and 1.0 (0.8–1.2), respectively,
and were similar for all CVD. Although no
trend was seen between the two highest-
exposed zones at the 20-year follow-up, a sig-
nificantly elevated RR for all circulatory
disease was seen among the men in the high-
est-exposed zone, but only within 10 years of
the accident (Consonni D, personal commu-
nication; data not shown), leading the authors
to hypothesize that psychosocial stress was the
cause (Bertazzi et al. 2001).
The IHD SMRs (95% CIs) for the IARC
and NIOSH studies from lowest to highest
exposure using the same categories as shown
in Table 2, were 0.85 (0.77–0.94) and 0.97
(0.90–1.04) for IARC (Vena et al. 1998) and
the SMRs were 0.93, 1.00, 1.05, 0.97, 1.10,
1.20, and 1.28 for NIOSH (Steenland et al.
1999) (no 95% CIs were shown; p-trend =
Dioxins and cardiovascular disease mortality
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Table 1. RRs (95% CIs) for mortality from IHD and all CVD from both internal and external comparisons with
crude exposure assessments, in dioxin-exposed cohorts.
Comparison type/cohort No. IHD All CVD Reference
External
Canadian sawmilla 23,829 NA 0.74 (0.71–0.76) Hertzman et al. 1997
Seveso 6,745 1.00 (0.8–1.2) 1.00 (0.8–1.1) Bertazzi et al. 2001
NIOSH 5,132 1.09 (1.00–1.20) NA Steenland et al. 1999
Finnish sprayers 1,909 0.94 (0.80–1.10) NA Asp et al. 1994
Yucheng 1,823 NA 1.00 (0.8–1.3) Tsai et al. 2007
Hamburg 1,177 0.97 (0.77–1.22) 1.06 (0.90–1.24) Flesch-Janys et al. 1998
New Zealand 
Production 813  1.04 (0.74–1.43) 0.96 (0.72–1.27) ‘t Mannetje et al. 2005
Sprayers 699  0.49 (0.31–0.75) 0.52 (0.36–0.73)
Dutch 549 1.20 (0.8–1.6) 1.00 (0.8–1.4) Hooiveld et al. 1998
BASF 243 0.70 (0.4–1.1) 0.80 (0.6–1.2) Ott and Zober 1996
Internal
Ranch Hand 20,340 NA 1.30 (1.0–1.6) Ketchum and Michalek 2005
Army Chemical Corps 5,609 NA 1.06 (0.62–1.82) Dalager and Kang 1997
NA, data not available. 
aUsing an alternate method of estimating person-time, the SMR for all CVD was 1.14 (1.10–1.18).
Table 2. RRs (95% CIs) for mortality from IHD and all CVD from internal comparisons, by dioxin exposure
level.
Study No. IHD All CVD
IARC (Vena al. 1998), TCDD/HCD exposure 21,384
No 7,553 1.00 (—) 1.00 (—)
Yes 13,831 1.67 (1.23–2.26) 1.51 (1.17–1.96)
NIOSHa (Steenland et al. 1999), cumulative exposure 3,538
0 to < 19 505 1.00 (—) NA
19 to < 139 505 1.23 (0.75–2.00) NA
139 to < 581 505 1.34 (0.83–2.18) NA
581 to < 1,650 505 1.30 (0.79–2.13) NA
1,650 to < 5,740 505 1.39 (0.86–2.24) NA
5,740 to < 20,200 505 1.57 (0.96–2.56) NA
≥ 20,200 505 1.75 (1.07–2.87) NA
Trend p-value = 0.05
Ranch Handb (Ketchum and Michalek 2005),  2,452
dioxin exposure category (ppt lipid)
Comparison 1,436 NA 1.00 (—)
Background 442 NA 0.80 (0.4–1.8)
Low (32.2–117.4) 287 NA 1.80 (0.9–3.5)
High (117.9–4221.9) 287 NA 1.50 (0.7–3.3)
Trend p-value = 0.07
Hamburgc (Flesch-Janys et al. 1995),  1,177
total I-TEQ (ng/kg lipid)
1.19–39.5 471 1.00 (—) 1.00 (—)
39.6–98.9 235 0.85 (0.41–1.75) 1.34 (0.85–2.13)
99.0–278.5 235 0.86 (0.41–1.83) 1.18 (0.71–1.95)
278.6–545.2 118 1.31 (0.57–3.00) 1.21 (0.66–2.25)
545.3–4361.9 118 1.89 (0.79–4.51) 1.40 (0.71–2.76)
Trend p-value = 0.03 Trend p-value = 0.05
Dutchd (Hooiveld et al. 1998), TCDD dose (ppt lipid) 1,031
Low (7.1) 530 1.00 (—) 1.00 (—)
Medium (7.7–124.1) 259 1.50 (0.7–3.6) 1.50 (0.8–2.8)
High (124.2–7307.5) 242 2.30 (1.0–5.0) 1.50 (0.8–2.9)
BASFe (Ott and Zober 1996), estimated TCDD dose  243
1 μg/kg increase NA 0.93 (0.70–1.24)
Abbreviations: HCD, higher chlorinated dioxins; NA, data not available.
aThe number for each exposure group was estimated by dividing the sample into septiles, as done by Steenland et al.
(1999). The cumulative exposure measure is a relative ranking; the units cannot be interpreted as a speciﬁc dose of dioxin.
bThe serum dioxin levels were extrapolated back to the end of service in Vietnam. No extrapolated dioxin levels were pre-
sented for the comparison or background categories. cThe number for each exposure group was estimated by combining
the two lowest quintiles and halving the highest quintile, as done by Flesch-Janys et al. (1995). The serum dioxin levels
were extrapolated back to the end of occupational exposure. dThe serum dioxin levels were extrapolated back to the end
of occupational exposure. eThis study presented the RR for all CVD only for a 1-μg/kg increase in estimated TCDD dose.0.14). In the BASF study (Ott and Zober
1996), the IHD SMRs corresponding to the
exposure categories of < 0.1, 0.1–0.99, and
≥ 1 µg/kg TCDD body weight were 0.9
(0.3–1.8), 0.7 (0.2–1.7), and 0.6 (0.2–1.3),
respectively. All of these results are qualita-
tively similar to the internal comparison
results for each study.
Detailed exposure assessments, with inter-
nal comparisons. Table 2 presents the results
that we considered to be the highest quality
according to our criteria, because the studies
used both internal comparisons and more
detailed exposure assessments. The data from
Table 2 are shown graphically in Figure 2
(IHD) and Figure 3 (all CVD). Dose-related
increases in IHD mortality were seen in all
four studies reporting this outcome (Table 2,
Figure 2). p-Values for trend were calculated in
the NIOSH (Steenland et al. 1999) and
Hamburg (Flesch-Janys et al. 1995) studies
and were p = 0.05 and p = 0.03, respectively.
The RR in the highest exposure group was sig-
nificantly elevated in the IARC (Vena et al.
1998), NIOSH (Steenland et al. 1999), and
Dutch (Hooiveld et al. 1998) studies. 
For all-CVD mortality, the dose-related
increases in mortality were less clear than for
IHD (Table 2, Figure 3). p-Values for trend
given for the Ranch Hand (Ketchum and
Michalek 2005) and Hamburg (Flesch-Janys
et al. 1995) studies were p = 0.07 and p = 0.05,
respectively. The RR for all-CVD mortality in
the highest exposure group was significantly
elevated in the IARC study (Vena et al. 1998),
but not in the others. The BASF study (Ott
and Zober 1996) found no association of
dioxin with all CVD.
A major concern in all the reviewed stud-
ies was potential confounding by the major
risk factors for CVD (e.g., diet, smoking,
physical activity). If these risk factors were
strongly associated with dioxin exposure, they
could confound the association between diox-
ins and CVD, biasing it either upward or
downward. Of the studies in Table 2, only the
Ranch Hand (Ketchum and Michalek 2005)
and BASF (Ott and Zober 1996) studies
adjusted for possible confounding by some of
the major risk factors for CVD [smoking and
family history of heart disease in Ranch Hand;
smoking and body mass index (BMI) in
BASF]. The Ranch Hand study found moder-
ately elevated adjusted RRs for all CVD (p for
trend = 0.07). The BASF study found no ele-
vated adjusted RRs for all CVD. Neither
study examined IHD, and neither study pre-
sented crude RRs, which otherwise could have
been compared with the adjusted RRs to assess
the strength of confounding.
The Hamburg study (Flesch-Janys et al.
1995) reported stronger trends using esti-
mated total I-TEQ [toxic equivalencies of
each dioxin relative to TCDD (North Atlantic
Treaty Organization, Committee on the
Challenges of Modern Society 1988)] than
using only estimated TCDD concentration
(data not shown). The TEQ results, which
represent the cumulative potency of the
multiple dioxin congeners, are considered
more biologically relevant than using TCDD
alone. The Hamburg study was the only study
to use both measures.
Discussion
The present review synthesizes the epidemio-
logic studies of dioxin and CVD mortality and
advances our understanding by considering in
detail the studies according to their quality.
Studies using external comparisons and crude
exposure estimates found no association
between dioxin exposure and increased risk of
IHD or all-CVD mortality, but this may be
due to healthy worker effect bias (McMichael
1976; Monson 1986; Weed et al. 1987) and
nondifferential misclassification of exposure.
In contrast, the higher-quality studies using
internal comparisons and detailed exposure
assessments found a consistent association
between dioxin exposure and increased risk of
IHD mortality, and a relatively weaker
association between dioxin exposure and risk
of all-CVD mortality. However, only two of
these studies adjusted for possible confound-
ing by some of the major risk factors for
CVD. Additionally, it is not possible to deter-
mine from the published data whether the
association between dioxin exposure and all
CVD would persist if we excluded IHD cases. 
The Seveso study (Bertazzi et al. 2001) was
the only large study to report no exposure–
response increase in CVD mortality, despite
stratiﬁcation of the exposed into low and high
categories, both of which were compared with
an external referent group. Although the reason
for the different results is unknown, the Seveso
study differs from the other studies in several
important respects. The Seveso study popula-
tion had a younger age structure, and the
TCDD exposure due to an industrial accident
was acute and was assessed ecologically.
Whether these factors partially account for the
different results is unknown.
Limitations. The major limitation of these
epidemiologic studies is the lack of adjustment
for other major risk factors for CVD (includ-
ing smoking, lack of physical activity, poor
diet, and alcohol consumption). Only age was
consistently adjusted for. The Ranch Hand
(Ketchum and Michalek 2005) and BASF
(Ott and Zober 1996) studies adjusted for
some of the potential risk factors for CVD,
but because the crude RRs were not shown,
the magnitude of confounding could not be
assessed. Several authors have suggested that
potential confounders in occupational mortal-
ity studies are unlikely to be sufficiently
highly correlated with both the exposure and
the outcome to completely explain a positive
association of the magnitude seen here (Blair
et al. 2007; Kriebel et al. 2004; Siemiatycki
et al. 1988). However, the possibility that the
associations are affected by uncontrolled con-
founding cannot be excluded.
Some recent cross-sectional studies of
dioxin exposure and CVD morbidity have
found associations that persisted after more
thorough adjustment for confounding (Ha
et al. 2007; Kang et al. 2006; Kim et al.
2003). Ha et al. (2007) reported an associa-
tion between PCDDs (but not PCDFs) and
self-reported CVD in the 1999–2002
National Health and Nutrition Examination
Study (NHANES). The adjusted odds ratios
(ORs), by PCDD exposure quartile, in both
sexes combined were 1.0 (reference category),
Humblet et al.
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Figure 2. RRs (95% CIs) for IHD mortality from inter-
nal comparisons, by quantiles of dioxin exposure
within each study. The exposure categories are not
necessarily equivalent across studies (Table 2).
The IARC study (Vena et al. 1998) includes the
Dutch study (Hooiveld et al. 1998) and earlier ver-
sions of the NIOSH (Steenland et al. 1999) and
Hamburg (Flesch-Janys et al. 1995) studies. 
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Study Figure 3. RRs (95% CIs) for all-CVD mortality from
internal comparisons, by quantiles of dioxin expo-
sure within each study. The exposure categories are
not necessarily equivalent across studies (Table 2).
The IARC study (Vena et al. 1998) includes the Dutch
study (Hooiveld et al. 1998) and an earlier version of
the Hamburg study (Flesch-Janys et al. 1995). The
BASF study (Ott and Zober 1996) presented the RR
only for a 1-μg/kg increase in estimated TCDD dose. 
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Study1.4, 1.7, and 1.9 (p for trend = 0.07) after
adjustment for age, race, BMI, smoking, alco-
hol consumption, exercise, cholesterol, hyper-
tension, and C-reactive protein. No crude
ORs were shown. Kang et al. (2006), in a
study of Army Chemical Corps Vietnam vet-
erans, found that spraying phenoxy herbicides
was associated with an OR (95% CI) for self-
reported heart disease of 1.41 (1.06–1.89),
adjusting for age, BMI, and regular smoking.
However, other cross-sectional studies of
cardiovascular morbidity have not found sig-
nificant associations with dioxin exposure
(Calvert et al. 1998), indicating that more
research is needed. The human evidence relat-
ing dioxins to potential intermediate causes of
CVD, such as serum lipids, is similarly mixed
[U.S. Environmental Protection Agency
(EPA) 2004].
The associations between dioxin exposure
and increased risk of cardiovascular mortality
were in study populations with dioxin levels
substantially higher than U.S. general popula-
tion levels (Ferriby et al. 2007; Patterson et al.
2008). However, Ha et al. (2007), using
NHANES data, found an association between
dioxin exposure and increasing prevalence of
heart disease at U.S. general population levels.
Several of the occupational studies that we
reviewed presented the RRs among workers
with low-to-moderate exposure levels that
could be relevant to the general population.
Although the RRs at low dioxin levels were ele-
vated in several studies, the CIs were wide and
the exposure categories were too broad to draw
ﬁrm conclusions. More research is needed to
characterize the CVD risk of low-level expo-
sures, both in animal and in human studies.
The RRs from internal comparisons across
the various studies are similar, even though the
mean exposure levels differ. However, in each
case the highest exposed category consisted of
individuals with estimated exposures of com-
parable magnitude (Table 2). Therefore, the
similar RRs seen in the highest-exposed group
of each study may truly be due to similar
exposures in this group. It is also worth noting
that the CIs around each RR are very wide,
indicating that, for example, the slightly larger
RR seen in the highest exposure group of the
Dutch study (Hooiveld et al. 1998) compared
with the Hamburg study (Flesch-Janys et al.
1995) (RR = 2.3 vs. RR = 1.89) might only be
the result of sampling variability because their
95% CIs overlap considerably (1.0–5.0 vs.
0.79–4.51). Additionally, the magnitude of an
RR can be affected by uncontrolled confound-
ing or by the background rate of CVD in the
referent group, which are also likely to vary
among studies.
Another weakness of the reviewed mor-
tality studies is the difficulty of accurately
retrospectively assessing personal exposure.
However, this exposure misclassification is
likely to be nondifferential with respect to
CVD mortality, which would tend to decrease
the observed associations in the highest expo-
sure category (Blair et al. 2007; Dosemeci
et al. 1990).
Most studies reported results only for
TCDD, and not total TEQ, which is consid-
ered more biologically relevant. In addition,
dioxin exposure was usually accompanied by
coexposure to other contaminants, whose pre-
cise composition varied within occupational
settings, and between occupational and envi-
ronmental settings. It is a limitation of epi-
demiologic studies that separating out the
effect of any one speciﬁc contaminant is difﬁ-
cult, especially given the possibility of syner-
gism or antagonism. The primary occupational
coexposure was to chlorophenols and their
derivatives, but the available toxicologic studies
of chlorophenols do not suggest that they have
toxic effects on the cardiovascular system
[Agency for Toxic Substances and Disease
Registry (ATSDR) 1999].
Our findings do not directly address the
risks of dioxin exposure for females because
none of the internal comparison studies
included substantial numbers of women. In a
general population morbidity study, Ha et al.
(2007) found very similar effects for men and
women. However, another recent study found
associations between dioxin exposure and mor-
tality from both chronic rheumatoid heart dis-
ease and hypertension in women but not in
men, whereas the association between dioxin
exposure and mortality from all circulatory dis-
eases was stronger in men (Consonni et al.
2008). Of the four animals studies we noted
above, three used female animals (Dalton et al.
2001; Jokinen et al. 2003; Lind et al. 2004)
and one used males (Kopf et al. 2007), and all
observed cardiovascular effects. The limited
evidence suggests that both sexes are sensitive
to the cardiovascular effects of dioxins,
although the possibility of the type and severity
of effects differing by sex cannot be excluded.
The downward bias of the SMRs of occu-
pational studies due to the healthy worker
effect complicates their interpretation. This
bias is illustrated by the substantially stronger
associations found using internal comparisons
than using SMRs in the IARC (Vena et al.
1998) and NIOSH (Steenland et al. 1999)
studies, despite the same exposure categories
being used for both analyses. 
Although information on the mortality
status of the participants was available at the
time of the retrospective exposure assessment,
this was unlikely to influence the estimation
process in a way that might induce a relation-
ship between the estimated dioxin exposure
and CVD mortality because the a priori focus
of these studies was cancer mortality.
These studies were also limited by their
reliance on mortality and death certificate
diagnoses. However, CVD mortality is likely
to be diagnosed relatively accurately, and any
errors would affect the precision but not the
validity of the results. Virtually identical
International Classification of Diseases, Ninth
Revision (WHO 1978) codes were used to
deﬁne IHD and all CVD in each study. 
The IARC internal comparison results at
least partially include the results from three of
the other internal comparison studies (Flesch-
Janys et al. 1995; Hooiveld et al. 1998;
Steenland et al. 1999; described in “Methods”
and in Figures 2 and 3). This raises the ques-
tion of whether the associations reported in
the IARC study might be solely due to its
inclusion of these three studies. This seems
unlikely, however, because the magnitude of
the associations seen in the IARC study is
similar to those seen in these three studies
(Table 2), even though they represent only
approximately 25% of the total number of
participants included in IARC.
Conclusions
The results of this systematic review suggest
that dioxin exposure is associated with increased
risk of mortality from both IHD and all CVD,
although more strongly with the former.
Although biological plausibility is provided by
animal studies, uncontrolled confounding by
other risk factors for CVD cannot be ruled out
as a contributor to the association.
We hope our results will stimulate further
evaluation of CVD incidence and mortality
in dioxin-exposed cohorts, especially using
internal comparisons with detailed exposure
assessments, and careful control for con-
founding. Future studies in both animals and
humans should assess whether cardiovascular
effects are present at environmentally relevant
doses. Of additional interest would be analy-
sis of whether the association between dioxin
exposure and all CVD persists when IHD
cases are excluded, as well as a pooled or
meta-analysis of the internal comparison
results in order to obtain a dose–response
curve for dioxin and CVD.
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